It is administered subcutaneously (into the fatty layer under the skin) for over 2-5 minutes once every three weeks.
In patients with adjuvant breast cancer, Trastuzumab can be given for 52 weeks or until disease recurrence, whichever occurs first. Extending the treatment beyond one year is not recommended.
2. Breastfeeding
3. Allergy to Trastuzumab
In patients with adjuvant breast cancer, Trastuzumab can be given for 52 weeks or until disease recurrence, whichever occurs first. Extending the treatment beyond one year is not recommended.
Dosage & When it is to be taken
Trastuzumab is available as injection: In a single vial of injection, 600 mg trastuzumab and 10,000 units hyaluronidase is available.When it is not to be taken (Contraindications)
1. Pregnancy2. Breastfeeding
3. Allergy to Trastuzumab
